Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian markets open firm
Wed, 25 Feb 09:30 am

Major Asian stock markets have opened the day in green with Korea market (up 0.8%) and Taiwan market (up 0.5%), leading the gainers. The Indian markets have also opened on a strong note. Barring FMCG, all the sectoral indices are trading in the green. Oil & gas and consumer durable stocks are trading on a firm footing.

BSE-Sensex is currently trading up by about 225 points (up 0.78%), while the NSE-Nifty is higher by about 63 points (up 0.72%). The BSE Mid Cap has opened the day in green, up by 0.63% and BSE Small Cap has opened strong, up by 0.84%. The rupee was trading at Rs 62.04 to the dollar.

Majority of the FMCG stocks are trading in the green with Jyothy Labs and Lakshmi Energy being the major gainers. However, Colgate and Emami are among the few stocks trading in the red. As per a leading financial daily, Godrej Consumer Products Ltd (GCPL) has increased its stake in Darling South Africa and Mozambique businesses to 90%. This is line with the company's aim of scaling its ownership in the Darling business. The Darling Group has a presence in 14 countries and sells hair extension products under the brands Darling and Amigos. The company has recently acquired South Africa's hair extension business Frika Hair to consolidate its market share in South Africa. As per the company, the South African business currently contributes revenues of $ 2 bn. GCPL had acquired 51% stake in Darling South Africa and Darling Mozambique in 2011. GCPL stock is currently trading up by 1.6%.

Most of the automobile stocks are trading up with Force Motors and TVS Motors being the major gainers. As per a leading financial daily, Tata Motors is developing its own quadricycle with a new petrol engine. under the 'project Bravo' . Reportedly, the quadricycle would be based on Tata's Iris light commercial vehicle platform and is slated to hit the roads in 2018. In this category, Bajaj Auto already has a lead with RE60. Even Piaggio and Mahindra are in a fray to develop their own quadricycles. It is to be noted that Tata Motors had earlier criticized quadricycles for being low in safety standards.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian markets open firm". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.